Atrial fibrillation trials recruiting in Vermont

All Atrial fibrillation trials nationally

Cities in Vermont

Recruiting trials in Vermont

• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Vermont: Burlington
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Vermont: Burlington
• Endocardial Mapping With the CoreMap EP Mapping System
  NCT06529978 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Vermont: Burlington